Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Nov 2020 for Stoke Therapeutics, Inc., €12.3M.
Filing timeline
BuySaleApple Tree Partners IV, L.P.
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Positive at T+90
50%
Median T+90
+4.5%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -50.9%Entry US$51.17 · Close at T+365 US$25.11
- -6.7%Entry US$25.53 · Close at T+365 US$23.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Apple Tree Partners IV, L.P.: trading record in brief
Apple Tree Partners IV, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Stoke Therapeutics, Inc. and Akero Therapeutics, Inc. The record holds 9 filings, for trades running from 21 June 2019 to 24 November 2020.
On the market, this insider has only ever bought: 4 purchases, €60.3M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2020, the count stands at 2 purchases and no sales.
In size, the median ticket on the buying side is €12.9M. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 25 November 2020: an open-market purchase of €12.3M, in Stoke Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Apple Tree Partners IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
375,000 shares@ US$39.00100.0% of flowCommon StockSEC:0001209191-20-060542:0
Canonical exit: 22 Feb 2021 (T+90)
415,000 shares@ US$36.00100.0% of flowCommon StockSEC:0001104659-20-083455:0
Canonical exit: 8 Oct 2020 (T+90)
4,228,764 sharesCommon StockSEC:0001104659-19-037457:0
286,439 sharesCommon StockSEC:0001104659-19-037457:1
900,000 shares@ US$16.0048.8% of flowCommon StockSEC:0001104659-19-037457:2
Canonical exit: 22 Sept 2019 (T+90)
4,980,168 shares0Common StockSEC:0001567619-19-013838:0
7,617,746 shares0Common StockSEC:0001567619-19-013838:1
2,799,910 shares0Common StockSEC:0001567619-19-013838:2
1,388,889 shares@ US$18.0064.2% of flowCommon StockSEC:0001567619-19-013838:3
Canonical exit: 19 Sept 2019 (T+90)
9 of 9 declarations
